The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...
Learn more about whether Legend Biotech Corporation or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether Twist Bioscience Corporation or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback